• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中国老年特应性皮炎的多中心临床流行病学分析]

[Multicenter clinical epidemiological analysis of elderly atopic dermatitis in China].

作者信息

Jiang X, Zhao J H, Tang H Y, Wang R J, Zhang D J, Wang Y, Li H, Hao F

机构信息

Dermatology and Plastic Surgery Center, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.

Department of Dermatology and Venerology, Peking University First Hospital & National Clinical Research Center for Skin and Immune Disease & Beijing Key Laboratory of Molecular Diagnosis of Dermatoses & NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing 100034, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2023 Aug 29;103(32):2495-2501. doi: 10.3760/cma.j.cn112137-20230517-00814.

DOI:10.3760/cma.j.cn112137-20230517-00814
PMID:37650195
Abstract

To investigate and analyze the clinical features of elderly atopic dermatitis (AD) in China. Based on the National Clinical Research and Homogeneous Diagnosis and Treatment Project for Type 2 Inflammation Dermatosis, a total of 2 281 patients aged 65 years or older were enrolled from 172 grade A tertiary hospitals who were diagnosed as atopic dermatitis from June 2021 to February 2023, and their demographics, clinical feature, and disease severity, etc. were collected. Elderly AD patients were divided into groups based on gender, history of allergic diseases (with or without a personal or family history of allergic diseases), and clinical features (site of onset, AD signs) and scales were compared within the groups. Median (, ) was used for quantitative data. The age of 2 281 elderly AD patients was 73.02 (68.83, 79.62) years old, among whom there were 1 649 males (72.29%) and 632 females (27.71%). A total of 2 244 cases were recorded with the information of the onset stage, of whom 1 713 cases (76.34%) occurred in the elderly stage. A total of 2 136 cases were recorded with the information of personal or family history of allergic diseases, of which 1 076 cases (50.37%) had a personal or family history of allergic diseases, and 1 060 (49.63%) had no history of allergic diseases. Skin lesions were predominantly involved in the waist, back, buttocks, and AD signs were mainly eczema-like skin lesions on the cheek and/or scalp and/or limb extension. Patients with moderate to severe AD accounted for 60.58% (1 327 cases), moderate to severe itching accounted for 81.32% (1 781 cases). Patients with anxiety and depression accounted for 46.14% (1 011 cases) and 39.27% (860 cases), respectively. Men had a higher EASI score than women [9.67 (4.77, 19.28) vs 8.45 (3.98, 17.11), =0.040]. EASI, HADS-anxiety and WI-NRS scores were higher in patients with history of allergic diseases than those without allergy history [ (9.79 (4.84, 19.96) vs 8.96 (4.05, 18.31), =0.015; 7.22 (3.49, 10.00) vs 6.81 (3.12, 9.33), =0.012; 7.64 (5.62, 9.07) vs 7.38 (5.35, 8.91), =0.036]. Elderly AD patients have their own exclusive clinical manifestations, and the understanding of these characteristics is beneficial for guiding clinical development of targeted management plans. Elderly AD patients are mostly senile onset, and male patients are more than female patients, skin lesions are mainly distributed on the extended side, and the disease burden is heavy.

摘要

调查分析我国老年特应性皮炎(AD)的临床特征。基于国家2型炎症性皮肤病临床研究与同质化诊疗项目,从172家三级甲等医院纳入2021年6月至2023年2月期间诊断为特应性皮炎的2281例65岁及以上患者,收集其人口统计学资料、临床特征、疾病严重程度等。老年AD患者根据性别、过敏性疾病史(有无个人或家族过敏性疾病史)、临床特征(发病部位、AD体征)分组,并比较组内量表情况。定量资料采用中位数(,)表示。2281例老年AD患者年龄为73.02(68.83,79.62)岁,其中男性1649例(72.29%),女性632例(27.71%)。共记录2244例发病阶段信息,其中1713例(76.34%)发生于老年期。共记录2136例个人或家族过敏性疾病史信息,其中1076例(50.37%)有个人或家族过敏性疾病史,1060例(49.63%)无过敏性疾病史。皮肤损害主要累及腰、背、臀部,AD体征主要为面颊和/或头皮和/或肢体伸侧的湿疹样皮肤损害。中度至重度AD患者占60.58%(1327例),中度至重度瘙痒患者占81.32%(1781例)。焦虑和抑郁患者分别占46.14%(1011例)和39.27%(860例)。男性的EASI评分高于女性[9.67(4.77,19.28)对8.45(3.98,17.11),=0.040]。有过敏性疾病史患者的EASI、HADS焦虑和WI-NRS评分高于无过敏史患者[(9.79(4.84,19.96)对8.96(4.05,18.31),=0.015;7.22(3.49,10.00)对6.81(3.12,9.33),=0.012;7.64(5.62,9.07)对7.38(5.35,8.91),=0.036]。老年AD患者有其独特的临床表现,了解这些特征有利于指导制定针对性的临床管理方案。老年AD患者多为老年期发病,男性多于女性,皮肤损害主要分布于伸侧,疾病负担较重。

相似文献

1
[Multicenter clinical epidemiological analysis of elderly atopic dermatitis in China].[中国老年特应性皮炎的多中心临床流行病学分析]
Zhonghua Yi Xue Za Zhi. 2023 Aug 29;103(32):2495-2501. doi: 10.3760/cma.j.cn112137-20230517-00814.
2
Clinical Characteristics of Atopic Dermatitis in Korean School-Aged Children and Adolescents According to Onset Age and Severity.根据发病年龄和严重程度分析韩国学龄儿童和青少年特应性皮炎的临床特征。
J Korean Med Sci. 2022 Jan 24;37(4):e30. doi: 10.3346/jkms.2022.37.e30.
3
Prevalence and clinical features of adult atopic dermatitis in tertiary hospitals of China.中国三级医院成人特应性皮炎的患病率及临床特征
Medicine (Baltimore). 2017 Mar;96(11):e6317. doi: 10.1097/MD.0000000000006317.
4
Risk Factors in Outpatients with Dermatitis and Eczema in Tertiary Hospitals of China Who Have Clinically Suspected Bacterial Infection.中国三级医院中患有皮炎和湿疹的门诊患者的细菌感染临床疑似病例的危险因素。
Biomed Res Int. 2020 Nov 27;2020:7621217. doi: 10.1155/2020/7621217. eCollection 2020.
5
Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.美国成年人特应性皮炎中焦虑和抑郁的症状和诊断。
Br J Dermatol. 2019 Sep;181(3):554-565. doi: 10.1111/bjd.17683. Epub 2019 Mar 5.
6
Current epidemiology of atopic dermatitis in south-eastern Nigeria.尼日利亚东南部特应性皮炎的当前流行病学情况。
Int J Dermatol. 2004 Oct;43(10):739-44. doi: 10.1111/j.1365-4632.2004.02360.x.
7
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.湿疹和特应性皮炎患者金黄色葡萄球菌皮肤定植及相关联合局部治疗:一项双盲多中心随机对照试验
Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x.
8
Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients.基于机器学习的特应性皮炎深度表型分析:青少年和成年患者严重程度相关因素。
JAMA Dermatol. 2021 Dec 1;157(12):1414-1424. doi: 10.1001/jamadermatol.2021.3668.
9
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).度普利尤单抗治疗青少年中重度特应性皮炎的长期疗效和安全性:III 期开放标签扩展试验(LIBERTY AD PED-OLE)的第 52 周结果。
Am J Clin Dermatol. 2022 May;23(3):365-383. doi: 10.1007/s40257-022-00683-2. Epub 2022 May 14.
10
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.在一项开放性研究中,度普利尤单抗为中重度特应性皮炎成人患者提供了长达 4 年的可接受安全性和持续疗效。
Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.